Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus study
- PMID: 37926103
- DOI: 10.1016/S2213-2600(23)00370-3
Core outcome measurement instruments for use in clinical and research settings for adults with post-COVID-19 condition: an international Delphi consensus study
Abstract
Post-COVID-19 condition (also known as long COVID) is a new, complex, and poorly understood disorder. A core outcome set (COS) for post-COVID-19 condition in adults has been developed and agreement is now required on the most appropriate measurement instruments for these core outcomes. We conducted an international consensus study involving multidisciplinary experts and people with lived experience of long COVID. The study comprised a literature review to identify measurement instruments for the core outcomes, a three-round online modified Delphi process, and an online consensus meeting to generate a core outcome measurement set (COMS). 594 individuals from 58 countries participated. The number of potential instruments for the 12 core outcomes was reduced from 319 to 19. Consensus was reached for inclusion of the modified Medical Research Council Dyspnoea Scale for respiratory outcomes. Measures for two relevant outcomes from a previously published COS for acute COVID-19 were also included: time until death, for survival, and the Recovery Scale for COVID-19, for recovery. Instruments were suggested for consideration for the remaining nine core outcomes: fatigue or exhaustion, pain, post-exertion symptoms, work or occupational and study changes, and cardiovascular, nervous system, cognitive, mental health, and physical outcomes; however, consensus was not achieved for instruments for these outcomes. The recommended COMS and instruments for consideration provide a foundation for the evaluation of post-COVID-19 condition in adults, which should help to optimise clinical care and accelerate research worldwide. Further assessment of this COMS is warranted as new data emerge on existing and novel measurement instruments.
Copyright © 2023 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests SLG is the project coordinator of the Core Outcome Measures in Effectiveness Trials (COMET) Initiative. NLH has received payment and honoraria for lectures and presentations from Lancaster University. PRW is chair of the COMET Management Group. DM is a co-chair of the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) Global Paediatric Long COVID working group and a member of the ISARIC working group on long-term follow-up in adults. All other authors declare no competing interests.
Similar articles
-
Core outcome measurement set for research and clinical practice in post-COVID-19 condition (long COVID) in children and young people: an international Delphi consensus study "PC-COS Children".Eur Respir J. 2024 Mar 14;63(3):2301761. doi: 10.1183/13993003.01761-2023. Print 2024 Mar. Eur Respir J. 2024. PMID: 38359962 Free PMC article. Review.
-
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.Lancet Respir Med. 2022 Jul;10(7):715-724. doi: 10.1016/S2213-2600(22)00169-2. Epub 2022 Jun 14. Lancet Respir Med. 2022. PMID: 35714658 Free PMC article. Review.
-
Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting.Int J Lang Commun Disord. 2023 Jul-Aug;58(4):1017-1028. doi: 10.1111/1460-6984.12840. Epub 2022 Dec 30. Int J Lang Commun Disord. 2023. PMID: 36583427 Free PMC article.
-
A core outcome domain set for clinical research on capillary malformations (the COSCAM project): an e-Delphi process and consensus meeting.Br J Dermatol. 2022 Nov;187(5):730-742. doi: 10.1111/bjd.21723. Epub 2022 Jul 31. Br J Dermatol. 2022. PMID: 35762296 Free PMC article.
-
Developing a Core Outcome Set for Netherton Syndrome: An International Multi-Stakeholder e-Delphi Consensus Study.Dermatology. 2025;241(1):35-48. doi: 10.1159/000542215. Epub 2024 Nov 1. Dermatology. 2025. PMID: 39496226 Free PMC article.
Cited by
-
CHARACTERIZATION OF BASELINE SYMPTOMS AND FUNCTIONAL IMPAIRMENTS IN A LARGE COHORT OF OUTPATIENTS ATTENDING A LONG COVID REHABILITATION CLINIC IN THE UNITED KINGDOM.J Rehabil Med Clin Commun. 2024 Oct 30;7:39984. doi: 10.2340/jrm-cc.v7.39984. eCollection 2024. J Rehabil Med Clin Commun. 2024. PMID: 39512484 Free PMC article.
-
Long COVID Clinical Severity Types Based on Symptoms and Functional Disability: A Longitudinal Evaluation.J Clin Med. 2024 Mar 26;13(7):1908. doi: 10.3390/jcm13071908. J Clin Med. 2024. PMID: 38610673 Free PMC article.
-
Factors associated with phenotypes of dyspnea in post-COVID-19 condition: a cross-sectional study.Sci Rep. 2024 Jun 11;14(1):13387. doi: 10.1038/s41598-024-64370-4. Sci Rep. 2024. PMID: 38862585 Free PMC article.
-
Bridging the gap: strategies for recognizing and managing post-COVID conditions.Front Med (Lausanne). 2024 Nov 19;11:1395420. doi: 10.3389/fmed.2024.1395420. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39635598 Free PMC article.
-
Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia.BMJ Open. 2024 May 13;14(5):e085272. doi: 10.1136/bmjopen-2024-085272. BMJ Open. 2024. PMID: 38740499 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical